MYCOBACTERIUM W FOR USE IN TREATING CANCER
The present invention relates to increase in survival of mammals suffering from desmocollin 3 expressing cancers. Mycobacterium w is administered to mammals suffering from desmocollin-3 expressing cancers. The administration of 6 Mycobacterium w results in control of tumor and improvement in surviva...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
26.02.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to increase in survival of mammals suffering from desmocollin 3 expressing cancers. Mycobacterium w is administered to mammals suffering from desmocollin-3 expressing cancers. The administration of 6 Mycobacterium w results in control of tumor and improvement in survival. Mycobacterium w can also be used along with other therapeutic agent(s) / modalities as per the requirement. The squamous type of non small cell lung cancer is known to 9 be desmocollin-3 expressing cancer. Other cancers also express desmocollin-3.
La présente invention concerne l'augmentation de la survie de mammifères souffrant de cancers exprimant la desmocolline 3. Mycobactérium w est administré à des mammifères souffrant de cancers exprimant la desmocolline 3. L'administration de Mycobactérium w conduit à la maîtrise des tumeurs et à l'amélioration de la survie. Mycobactérium w peut également être utilisé avec un ou plusieurs autres agents thérapeutiques/modalités thérapeutiques selon le besoin. Le type squameux du cancer du poumon non à petites cellules est connu comme étant un cancer exprimant la desmocolline 3. D'autres cancers expriment également la desmocolline 3. |
---|---|
Bibliography: | Application Number: CA20122824417 |